Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis

Navjyot Hansi; Nora Thoua; Maresa Carulli; Kuntal Chakravarty; Simon Lal; Anita Smyth; Ariane Herrick; Olagunju Ogunbiyi; Jonathan Shaffer; John Mclaughlin; Christopher Denton; Voon Ong; Anton V Emmanuel; Charles D Murray

Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis

Navjyot Hansi, Nora Thoua, Maresa Carulli, Kuntal Chakravarty, Simon Lal, Anita Smyth, Ariane Herrick, Olagunju Ogunbiyi, Jonathan Shaffer, John Mclaughlin, Christopher Denton, Voon Ong, Anton V Emmanuel, Charles D Murray

Medical Education (L5)

Research output: Contribution to journal › Article › peer-review

Abstract

Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.

Original language	English
Pages (from-to)	214-221
Number of pages	7
Journal	Clinical and Experimental Rheumatology
Volume	32
Issue number	6 Suppl 86
Publication status	Published - 2014

Cite this

Hansi, N., Thoua, N., Carulli, M., Chakravarty, K., Lal, S., Smyth, A., Herrick, A., Ogunbiyi, O., Shaffer, J., Mclaughlin, J., Denton, C., Ong, V., Emmanuel, A. V., & Murray, C. D. (2014). Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis. Clinical and Experimental Rheumatology, 32(6 Suppl 86), 214-221.

@article{ab6ed3b4b42246be83072786d1cb1498,

title = "Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis",

abstract = "Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.",

author = "Navjyot Hansi and Nora Thoua and Maresa Carulli and Kuntal Chakravarty and Simon Lal and Anita Smyth and Ariane Herrick and Olagunju Ogunbiyi and Jonathan Shaffer and John Mclaughlin and Christopher Denton and Voon Ong and Emmanuel, {Anton V} and Murray, {Charles D}",

year = "2014",

language = "English",

volume = "32",

pages = "214--221",

journal = "Clinical and Experimental Rheumatology",

issn = "1593-098X",

publisher = "Clinical and Experimental Rheumatology S.A.S.",

number = "6 Suppl 86",

}

Hansi, N, Thoua, N, Carulli, M, Chakravarty, K, Lal, S, Smyth, A, Herrick, A, Ogunbiyi, O, Shaffer, J, Mclaughlin, J, Denton, C, Ong, V, Emmanuel, AV & Murray, CD 2014, 'Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis', Clinical and Experimental Rheumatology, vol. 32, no. 6 Suppl 86, pp. 214-221.

TY - JOUR

T1 - Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis

AU - Hansi, Navjyot

AU - Thoua, Nora

AU - Carulli, Maresa

AU - Chakravarty, Kuntal

AU - Lal, Simon

AU - Smyth, Anita

AU - Herrick, Ariane

AU - Ogunbiyi, Olagunju

AU - Shaffer, Jonathan

AU - Mclaughlin, John

AU - Denton, Christopher

AU - Ong, Voon

AU - Emmanuel, Anton V

AU - Murray, Charles D

PY - 2014

Y1 - 2014

N2 - Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.

AB - Systemic sclerosis is an autoimmune connective tissue disorder, which can be progressive with multisystem involvement. Guidance on the management of complications is based on a limited data set and practice amongst clinicians can vary. The UK Scleroderma study group set up several working groups to agree some consensus pathways for the management of specific complications. Approximately nine out of ten patients with systemic sclerosis will have involvement of the gastrointestinal system and in this review article we explore the management of these complications in a symptom-based approach. The algorithms are a useful tool for clinicians, which we hope, will be a point of reference and highlight the need for further research in these areas.

M3 - Article

C2 - 25372804

SN - 1593-098X

VL - 32

SP - 214

EP - 221

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

IS - 6 Suppl 86

ER -

Consensus Best Practice pathway of the UK Scleroderma Study Group: gastrointestinal manifestations of systemic sclerosis

Abstract

Fingerprint

Cite this